Groups advocating to force medtech manufacturers to provide tools and manuals to service their products are renewing efforts in state legislatures despite recent losses.
Right to repair proponents are gearing up for another year of legislative battles to push through bills that would force medtech manufacturers to give third parties the ability to service their products.
Advocates admit it’s an outsized fight, casting themselves as “David versus Goliath,” but they aim to pass bills in states like Pennsylvania and California that they hope will have a...
The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.
Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.
Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.
